Brain metastasis magnetic resonance imaging-based deep learning for predicting epidermal growth factor receptor (EGFR) mutation and subtypes in metastatic non-small cell lung cancer

被引:1
|
作者
Cao, Ran [1 ,2 ]
Fu, Langyuan [1 ]
Huang, Bo [3 ]
Liu, Yan [1 ]
Wang, Xiaoyu [4 ]
Liu, Jiani [4 ]
Wang, Haotian [4 ]
Jiang, Xiran [1 ]
Yang, Zhiguang [5 ]
Sha, Xianzheng [1 ]
Zhao, Nannan [4 ]
机构
[1] China Med Univ, Sch Intelligent Med, 77 Puhe Rd, Shenyang 110122, Peoples R China
[2] Fudan Univ, Sch Informat Sci & Technol, Dept Biomed Engn, Shanghai, Peoples R China
[3] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Pathol, Shenyang, Peoples R China
[4] China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Dept Radiol, 44 Xiaoheyan Rd, Shenyang 110042, Peoples R China
[5] China Med Univ, Shengjing Hosp, Dept Radiol, 36 Sanhao St, Shenyang 110004, Peoples R China
基金
国家重点研发计划;
关键词
Brain metastases (BM); epidermal growth factor receptor (EGFR); EGFR ); deep learning; non-small cell lung cancer (NSCLC); radiomics; OPEN-LABEL; EXON; 19; MUTANT; SURVIVAL; RESISTANCE; BIOMARKER; 1ST-LINE; IMAGES;
D O I
10.21037/qims-23-1744
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The preoperative identification of epidermal growth factor receptor ( EGFR ) mutations and subtypes based on magnetic resonance imaging (MRI) of brain metastases (BM) is necessary facilitate individualized therapy. This study aimed to develop a deep learning model to preoperatively detect EGFR mutations and identify the location of EGFR mutations in patients with non-small cell lung cancer (NSCLC) and BM. Methods: We included 160 and 72 patients who underwent contrast-enhanced T1-weighted (T1w-CE) and T2-weighted (T2W) MRI at Liaoning Cancer Hospital and Institute (center 1) and Shengjing Hospital China Medical University (center 2) to form a training cohort and an external validation cohort, respectively. A multiscale feature fusion network (MSF-Net) was developed by adaptively integrating features based different stages of residual network (ResNet) 50 and by introducing channel and spatial attention modules. The external validation set from center 2 was used to assess the performance of MSF-Net and to compare it with that of handcrafted radiomics features. Receiver operating characteristic (ROC) curves, accuracy, precision, recall, and F1-score were used to evaluate the effectiveness of the models. Gradient-weighted class activation mapping (Grad-CAM) was used to demonstrate the attention of the MSF-Net model. Results: The developed MSF-Net generated a better diagnostic performance than did the handcrafted radiomics in terms of the microaveraged area under the curve (AUC) (MSF-Net: 0.91; radiomics: 0.80) and macroaveraged AUC (MSF-Net: 0.90; radiomics: 0.81) for predicting EGFR mutations and subtypes. Conclusions: This study provides an end-to-end and noninvasive imaging tool for the preoperative prediction of EGFR mutation status and subtypes based on BM, which may be helpful for facilitating individualized clinical treatment plans.
引用
收藏
页码:4749 / 4762
页数:14
相关论文
共 50 条
  • [41] Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis
    Zhang, Qiuyi
    Zhang, Xuchao
    Yan, Honghong
    Jiang, Benyuan
    Xu, Chongrui
    Yang, Jinji
    Chen, Zhihong
    Su, Jian
    Wu, Yi-Long
    Zhou, Qing
    THORACIC CANCER, 2016, 7 (06) : 648 - 654
  • [42] Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer
    Gregorc, Vanesa
    Lazzari, Chiara
    Karachaliou, Niki
    Rosell, Rafael
    Santarpia, Mariacarmela
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S165 - S170
  • [43] Epidermal growth factor receptor (EGFR) expression in operable non-small cell lung carcinoma
    Ahn, JH
    Kim, SW
    Hong, SM
    Suh, C
    Kim, WK
    Lee, IC
    Lee, JS
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (04) : 529 - 535
  • [44] Characteristics Of Metastatic Brain Tumors From Non-Small Cell Lung Cancer With EGFR Mutation
    Sekine, A.
    Enomoto, Y.
    Oda, T.
    Kato, T.
    Hagiwara, E.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [45] Radiomics for the prediction of EGFR mutation subtypes in non-small cell lung cancer
    Li, Shu
    Ding, Changwei
    Zhang, Hao
    Song, Jiangdian
    Wu, Lei
    MEDICAL PHYSICS, 2019, 46 (10) : 4545 - 4552
  • [46] Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer
    Morinaga, Ryotaro
    Okamoto, Isamu
    Fujita, Yoshihiko
    Arao, Tokuzo
    Sekijima, Masaru
    Nishio, Kazuto
    Ito, Hiroyuki
    Fukuoka, Masahiro
    Kadota, Jun-ichi
    Nakagawa, Kazuhiko
    CANCER SCIENCE, 2008, 99 (12): : 2455 - 2460
  • [47] Population based study of the prevalence of epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC)
    Skov, B. G.
    Hogdall, E.
    Clementsen, P.
    Krasnik, M.
    Larsen, K. R.
    Sorensen, J. B.
    Mellemgaard, A.
    APMIS, 2012, 120 : 14 - 14
  • [48] Deep learning predicts epidermal growth factor receptor mutation subtypes in lung adenocarcinoma
    Song, Jiangdian
    Ding, Changwei
    Huang, Qinlai
    Luo, Ting
    Xu, Xiaoman
    Chen, Zongjian
    Li, Shu
    MEDICAL PHYSICS, 2021, 48 (12) : 7891 - 7899
  • [49] Complete remission through icotinib treatment in Non-small cell lung cancer epidermal growth factor receptor mutation patient with brain metastasis: A case report
    Wang, Tao
    Wang, Ruimin
    Dong, Zhouhuan
    Liang, Naichao
    Chang, Ping
    OPEN MEDICINE, 2016, 11 (01): : 11 - 15
  • [50] Brain Metastasis in Patients With Non-Small-Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Bhatt, Vijaya R.
    Kedia, Shiksha
    Kessinger, Anne
    Ganti, Apar K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3162 - 3164